JP2011511034A5 - - Google Patents

Download PDF

Info

Publication number
JP2011511034A5
JP2011511034A5 JP2010545458A JP2010545458A JP2011511034A5 JP 2011511034 A5 JP2011511034 A5 JP 2011511034A5 JP 2010545458 A JP2010545458 A JP 2010545458A JP 2010545458 A JP2010545458 A JP 2010545458A JP 2011511034 A5 JP2011511034 A5 JP 2011511034A5
Authority
JP
Japan
Prior art keywords
phenyl
pyrrolo
pyrimidin
ylmethyl
morpholin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010545458A
Other languages
English (en)
Japanese (ja)
Other versions
JP5323095B2 (ja
JP2011511034A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/051281 external-priority patent/WO2009098236A1/en
Publication of JP2011511034A publication Critical patent/JP2011511034A/ja
Publication of JP2011511034A5 publication Critical patent/JP2011511034A5/ja
Application granted granted Critical
Publication of JP5323095B2 publication Critical patent/JP5323095B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010545458A 2008-02-06 2009-02-04 ピロロ[2,3−d]ピリミジンおよびそのチロシンキナーゼ阻害剤としての使用 Expired - Fee Related JP5323095B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08151137 2008-02-06
EP08151137.0 2008-02-06
PCT/EP2009/051281 WO2009098236A1 (en) 2008-02-06 2009-02-04 Pyrrolo [2, 3-d] pyridines and use thereof as tyrosine kinase inhibitors

Publications (3)

Publication Number Publication Date
JP2011511034A JP2011511034A (ja) 2011-04-07
JP2011511034A5 true JP2011511034A5 (enExample) 2012-06-07
JP5323095B2 JP5323095B2 (ja) 2013-10-23

Family

ID=39739330

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010545458A Expired - Fee Related JP5323095B2 (ja) 2008-02-06 2009-02-04 ピロロ[2,3−d]ピリミジンおよびそのチロシンキナーゼ阻害剤としての使用

Country Status (27)

Country Link
US (1) US8420657B2 (enExample)
EP (1) EP2247591A1 (enExample)
JP (1) JP5323095B2 (enExample)
KR (2) KR101277823B1 (enExample)
CN (1) CN101981036B (enExample)
AR (1) AR070558A1 (enExample)
AU (1) AU2009211338B2 (enExample)
BR (1) BRPI0908433A2 (enExample)
CA (1) CA2714177A1 (enExample)
CL (1) CL2009000255A1 (enExample)
CO (1) CO6321262A2 (enExample)
CR (1) CR11614A (enExample)
DO (1) DOP2010000242A (enExample)
EA (1) EA017952B1 (enExample)
EC (1) ECSP10010463A (enExample)
IL (1) IL207224A0 (enExample)
MA (1) MA32134B1 (enExample)
MX (1) MX2010008719A (enExample)
NI (1) NI201000137A (enExample)
NZ (1) NZ587271A (enExample)
PA (1) PA8815201A1 (enExample)
PE (1) PE20091485A1 (enExample)
SM (1) SMP201000104B (enExample)
TW (1) TW200938202A (enExample)
UY (1) UY31631A1 (enExample)
WO (1) WO2009098236A1 (enExample)
ZA (1) ZA201005338B (enExample)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3235B1 (ar) 2006-05-26 2018-03-08 Astex Therapeutics Ltd مركبات بيررولوبيريميدين و استعمالاتها
US20110064671A1 (en) * 2008-03-10 2011-03-17 Cornell University Modulation of blood brain barrier permeability
ES2522346T3 (es) 2008-08-22 2014-11-14 Novartis Ag Compuestos de pirrolopirimidina como inhibidores de CDK
US8518933B2 (en) 2009-04-23 2013-08-27 Abbvie Inc. Modulators of 5-HT receptors and methods of use thereof
US8546377B2 (en) 2009-04-23 2013-10-01 Abbvie Inc. Modulators of 5-HT receptors and methods of use thereof
CN106986875A (zh) * 2009-04-23 2017-07-28 Abbvie 公司 5‑ht受体的调节剂和其使用方法
AU2010309882B2 (en) * 2009-10-20 2016-01-28 Cellzome Limited Heterocyclyl pyrazolopyrimidine analogues as JAK inhibitors
HUE033099T2 (en) * 2009-12-01 2017-11-28 Abbvie Inc Novel tricyclic compounds
US8791100B2 (en) 2010-02-02 2014-07-29 Novartis Ag Aryl benzylamine compounds
UY33227A (es) 2010-02-19 2011-09-30 Novartis Ag Compuestos de pirrolopirimidina como inhibidores de la cdk4/6
UY33226A (es) * 2010-02-19 2011-09-30 Novartis Ag Compuestos de pirrolopirimidina deuterada como inhibidores de la cdk4/6
MX2012012328A (es) 2010-04-30 2013-05-06 Cellzome Ltd Compuestos pirazol como inhibidores de jak.
US9586961B2 (en) 2010-07-09 2017-03-07 Leo Pharma A/S Homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof
US9040545B2 (en) 2010-08-20 2015-05-26 Cellzome Limited Heterocyclyl pyrazolopyrimidine analogues as selective JAK inhibitors
JP2013540748A (ja) * 2010-09-16 2013-11-07 コーネル ユニバーシティー 血液脳関門の透過性を調節するためのアデノシン受容体シグナル伝達の使用法
WO2012143320A1 (en) 2011-04-18 2012-10-26 Cellzome Limited (7h-pyrrolo[2,3-d]pyrimidin-2-yl)amine compounds as jak3 inhibitors
JP5832647B2 (ja) 2011-07-01 2015-12-16 ノバルティス アーゲー がんの治療における使用のためのcdk4/6阻害剤およびpi3k阻害剤を含む併用療法
WO2013041605A1 (en) 2011-09-20 2013-03-28 Cellzome Limited Pyrazolo[4,3-c]pyridine derivatives as kinase inhibitors
MX2014005927A (es) * 2011-11-15 2014-06-05 Novartis Ag Combinacion de un inhibidor de la fosfoinositida-3-cinasa y un modulador de la senda del transductor y activador de la señal de transcripcion 5 de la cinasa janus 2.
CN102627646A (zh) * 2012-03-19 2012-08-08 苏州四同医药科技有限公司 一种3-碘-5-溴-4,7-二氮杂吲哚的制备方法
CN102633802B (zh) * 2012-04-11 2014-03-19 南京药石药物研发有限公司 一种合成2-氯-7H-吡咯并[2,3-d]嘧啶的中间体及其制法
US9670213B2 (en) * 2012-05-14 2017-06-06 East China University Of Science And Technology Pteridine ketone derivative and applications thereof as EGFR, BLK, and FLT3 inhibitor
CN103059030B (zh) * 2012-12-28 2015-04-29 北京师范大学 一种具有粘着斑激酶抑制作用的嘧啶类化合物及其制备方法和应用
WO2014145576A2 (en) 2013-03-15 2014-09-18 Northwestern University Substituted pyrrolo(2,3-d)pyrimidines for the treatment of cancer
US20170137426A1 (en) * 2014-03-28 2017-05-18 Changzhou Jiekai Pharmatech Co., Ltd. Heterocyclic compounds as axl inhibitors
PL3137470T3 (pl) 2014-05-01 2021-10-11 Novartis Ag Związki i kompozycje jako agonisty receptora toll-like 7
ES2908150T3 (es) * 2014-05-01 2022-04-27 Novartis Ag Compuestos y composiciones como agonistas del receptor de tipo Toll 7
MA44334A (fr) 2015-10-29 2018-09-05 Novartis Ag Conjugués d'anticorps comprenant un agoniste du récepteur de type toll
CN112423759A (zh) 2018-03-30 2021-02-26 因赛特公司 使用jak抑制剂治疗化脓性汗腺炎
CN111484496B (zh) * 2019-01-29 2022-11-29 江苏开元药业有限公司 2-氨基-吡咯并嘧啶和吡唑并嘧啶类化合物及其制备方法和用途
CN114269734A (zh) 2019-05-08 2022-04-01 维玛兰生物科学公司 Jak抑制剂
CN110305140B (zh) * 2019-07-30 2020-08-04 上海勋和医药科技有限公司 二氢吡咯并嘧啶类选择性jak2抑制剂
MX2022001702A (es) * 2019-08-08 2022-04-20 Vimalan Biosciences Inc Inhibidores de jak.
GB201911868D0 (en) * 2019-08-19 2019-10-02 Galapagos Nv Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
US20220348590A1 (en) * 2019-09-13 2022-11-03 The Board Institute, Inc. Cyclooxygenase-2 inhibitors and uses thereof
GB201914910D0 (en) * 2019-10-15 2019-11-27 Sentinel Oncology Ltd Pharmaceutical compounds
CN117043163A (zh) * 2021-09-08 2023-11-10 希格生科(深圳)有限公司 吡咯并嘧啶类或吡咯并吡啶类衍生物及其医药用途
CN114957248B (zh) * 2022-05-09 2023-12-29 南开大学 一种吡咯并嘧啶化合物及其制备方法、药物组合物和应用
CN116813624B (zh) * 2023-06-29 2025-10-03 成都金瑞基业生物科技有限公司 一种jak2抑制剂的晶型及制备方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7917643B2 (en) * 1996-09-12 2011-03-29 Audible, Inc. Digital information library and delivery system
US20030074530A1 (en) * 1997-12-11 2003-04-17 Rupaka Mahalingaiah Load/store unit with fast memory data access mechanism
US6887224B2 (en) * 1998-06-15 2005-05-03 Ilse Rubio Close fitting leakage resistant feminine hygiene pad
RS50087B (sr) 1998-06-19 2009-01-22 Pfizer Products Inc., Pirolo (2,3-d) pirimidin jedinjenja
CZ303875B6 (cs) 1999-12-10 2013-06-05 Pfizer Products Inc. Pyrrolo[2,3-d]pyrimidinová sloucenina a farmaceutická kompozice s jejím obsahem
WO2002076985A1 (en) * 2001-03-23 2002-10-03 Smithkline Beecham Corporation Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
RU2301233C2 (ru) 2002-03-07 2007-06-20 Ф.Хоффманн-Ля Рош Аг Бициклические пиридины и пиримидины в качестве ингибиторов киназы р38
US7132221B2 (en) * 2003-09-12 2006-11-07 Headway Technologies, Inc. Method to print photoresist lines with negative sidewalls
US7532909B2 (en) * 2003-10-15 2009-05-12 Nextel Communications Inc. System and method for providing dedicated paging channels for walkie-talkie services
US7319102B1 (en) * 2003-12-09 2008-01-15 The Procter & Gamble Company Pyrrolo[2,3-d]pyrimidine cytokine inhibitors
PL1713806T3 (pl) * 2004-02-14 2013-09-30 Irm Llc Związki i kompozycje jako inhibitory kinaz białkowych
US20070270588A1 (en) 2004-03-05 2007-11-22 Taisho Pharmaceutical Co., Ltd. Pyrrolopyrimidine Derivatives
WO2005107760A1 (en) * 2004-04-30 2005-11-17 Irm Llc Compounds and compositions as inducers of keratinocyte differentiation
CA2577588C (en) * 2004-10-29 2013-09-10 Tibotec Pharmaceuticals Ltd. Hiv inhibiting bicyclic pyrimidine derivatives
US20060122003A1 (en) * 2004-12-03 2006-06-08 Kim Jong H Portable golf swing position training aid kit
AU2006205851A1 (en) 2005-01-14 2006-07-20 Janssen Pharmaceutica N.V. 5-membered annelated heterocyclic pyrimidines as kinase inhibitors
JP5227032B2 (ja) * 2005-02-03 2013-07-03 バーテックス ファーマシューティカルズ インコーポレイテッド プロテインキナーゼの阻害剤として有用なピロロピリミジン
JP2006241089A (ja) 2005-03-04 2006-09-14 Astellas Pharma Inc ピロロピリミジン誘導体またはその塩
CN101233135B (zh) 2005-05-05 2012-10-03 阿迪亚生命科学公司 用作非核苷反转录酶抑制剂治疗人免疫缺陷病毒的二芳基-嘌呤、二芳基-氮杂嘌呤和二芳基-脱氮嘌呤化合物
US7749527B2 (en) 2005-05-24 2010-07-06 Wyeth Llc Gel compositions for control of ecto-parasites
US20080004295A1 (en) 2005-10-13 2008-01-03 Gore Paul M Novel compounds
PT2385053E (pt) * 2005-11-17 2013-12-17 Osi Pharm Inc Intermediários para a preparação de compostos bicíclicos condensados como inibidores mtor
KR101391900B1 (ko) * 2005-12-13 2014-05-02 인사이트 코포레이션 야누스 키나아제 억제제로서의 헤테로아릴 치환된 피롤로[2,3-b]피리딘 및 피롤로[2,3-b]피리미딘
TW200812587A (en) 2006-03-20 2008-03-16 Synta Pharmaceuticals Corp Benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses
JO3235B1 (ar) 2006-05-26 2018-03-08 Astex Therapeutics Ltd مركبات بيررولوبيريميدين و استعمالاتها
JP4861772B2 (ja) * 2006-08-28 2012-01-25 富士通株式会社 移動体標定プログラム、該プログラムを記録した記録媒体、移動体標定装置、および移動体標定方法
CL2007002994A1 (es) * 2006-10-19 2008-02-08 Wyeth Corp Compuestos derivados heterociclicos que contienen sulfamoilo, inhibidores de hsp90; composicion farmaceutica; y uso para el tratamiento del cancer, tal como cancer de mama, de colon y prostata, entre otros.
CL2008001709A1 (es) 2007-06-13 2008-11-03 Incyte Corp Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras.
KR20090033605A (ko) * 2007-10-01 2009-04-06 삼성전자주식회사 적층형 반도체 패키지, 그 형성방법 및 이를 구비하는전자장치
US20090149458A1 (en) 2007-11-27 2009-06-11 Wyeth PYRROLO[3,2-d]PYRIMIDINE COMPOUNDS AND THEIR USE AS PI3 KINASE AND mTOR KINASE INHIBITORS
US8841312B2 (en) 2007-12-19 2014-09-23 Amgen Inc. Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors
US20090192176A1 (en) * 2008-01-30 2009-07-30 Wyeth 1H-PYRAZOLO[3,4-D]PYRIMIDINE, PURINE, 7H-PURIN-8(9H)-ONE, 3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE, AND THIENO[3,2-D]PYRIMIDINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES

Similar Documents

Publication Publication Date Title
JP2011511034A5 (enExample)
JP5323095B2 (ja) ピロロ[2,3−d]ピリミジンおよびそのチロシンキナーゼ阻害剤としての使用
JP6435323B2 (ja) 炎症性障害の治療のための新規化合物及びその医薬組成物
JP2022184886A5 (enExample)
ES2857081T3 (es) Compuestos de pirazolo[1,5-a]piridina sustituidos como inhibidores de la quinasa ret
JP2019535664A5 (enExample)
SI3083625T1 (en) Pyrimidopyrimidinones, useful as Wee-1 kinase inhibitors
JP2018044008A5 (enExample)
JP2016525092A5 (enExample)
RU2502737C2 (ru) Производные имидазопиридина или имидазопиримидина в качестве ингибиторов фосфодиэстеразы 10а
JP2015523387A5 (enExample)
RU2018138471A (ru) Гетероциклические соединения в качестве ингибиторов киназы RET
RU2019115115A (ru) Производные пиперидина в качестве ингибиторов убиквитин-специфической протеазы 7
JP2013523884A5 (enExample)
RU2014151004A (ru) Пирролопиримидоновые и пирролопиридоновые ингибиторы танкиразы
JP2015533822A5 (enExample)
JPWO2020005877A5 (enExample)
RU2012152548A (ru) Пиридоновые и азапиридоновые соединения и способы применения
HRP20151442T1 (hr) Spojevi heteroaril piridona i aza-piridona kao inhibitori btk-djelovanja
US20240059703A1 (en) Heterocyclic spiro compounds and methods of use
IL318278A (en) Imidazopyridazine and imidazopyridine compounds and their use
JP2025535046A (ja) Kras g12c変異タンパク質の複素環阻害剤及びその使用
RU2017141077A (ru) Ингибитор некоторых протеинкиназ
JP2023549055A (ja) 複素環式スピロ化合物及びその使用方法
JP2014511355A5 (enExample)